| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.3M | — | +35.7% |
| Cost of Revenue | $15.6M | — | +9.6% |
| Gross Profit | $11.7M | — | +99.3% |
| R&D Expense | $4.0M | — | +11.2% |
| SG&A Expense | $4.7M | — | -6.3% |
| Operating Income | $2.0M | — | +149.8% |
| Pre-tax Income | $2.2M | — | +165.6% |
| Income Tax | $107K | — | +107.3% |
| Net Income | $2.1M | — | +209.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.3M | +66.4% | +52.4% |
| Current Assets | $28.8M | -7.3% | -7.4% |
| Total Assets | $56.8M | -4.2% | -11.9% |
| Current Liabilities | $48.0M | -3.6% | +30.4% |
| Long-term Debt | $10.2M | -29.6% | +13.8% |
| Total Liabilities | $76.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.2M | — | +1235.1% |
| Investing Cash Flow | -$162K | — | +91.4% |
| Financing Cash Flow | -$4.3M | — | -237.9% |
| +25.7% |
| Stockholders' Equity | -$14.2M | +13.2% | -256.1% |